Although further investigations are necessary, HFn can be loaded with different chemotherapeutic compounds, becoming an innovative therapeutic tool for the treatment of cancers highly expressing TFR‐1 in veterinary and human medicine. The gene discussed is TFRC; the disease is cancer.